Gynecol Endocrinol. 2006 Nov;22(11):595-604.

Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?

Source

Department of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298-0111, USA.

Abstract

Insulin resistance is an important pathophysiological feature of the polycystic ovary syndrome (PCOS). Insulin resistance and its compensatory hyperinsulinemia contribute to the anovulation, hyperandrogenism, infertility and early pregnancy loss suffered by women with PCOS. Current evidence supports the role of metformin in the treatment of anovulation in PCOS, both in monotherapy and concomitantly with clomiphene in clomiphene-resistant patients. In addition, novel evidence suggests that insulin sensitizers may also play a role in reducing the risk of early pregnancy loss. The insulin-sensitizing agents available commercially include metformin, rosiglitazone and pioglitazone. Compared with the thiozolidinediones, metformin is the agent that has been most frequently studied in PCOS, and has the most favorable pregnancy safety profile. In conclusion, there is strong evidence supporting the use of metformin as a primary ovulatory agent in women with PCOS.

PMID:: 17145645; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

METFORMIN HYDROCHLORIDE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? [Reprod Biomed Online. 2004]
Review Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
Cheang KI, Nestler JE. Reprod Biomed Online. 2004 Apr; 8(4):440-7.
Review Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. [Acta Obstet Gynecol Scand. 2004]
Review Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
Saleh AM, Khalil HS. Acta Obstet Gynecol Scand. 2004 Jul; 83(7):614-21.
Review Treatment of PCOS with metformin and other insulin-sensitizing agents. [Curr Diab Rep. 2004]
Review Treatment of PCOS with metformin and other insulin-sensitizing agents.
Seli E, Duleba AJ. Curr Diab Rep. 2004 Feb; 4(1):69-75.
Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases. [J Reprod Med. 2000]
Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
Seale FG 4th, Robinson RD, Neal GS. J Reprod Med. 2000 Jun; 45(6):507-10.
Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. [Fertil Steril. 2002]
Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.
Kocak M, Caliskan E, Simsir C, Haberal A. Fertil Steril. 2002 Jan; 77(1):101-6.

See reviews... See all...

Cited by 4 PubMed Central articles

Gerosuppressant metformin: less is more. [Aging (Albany NY). 2011]
Gerosuppressant metformin: less is more.
Menendez JA, Cufí S, Oliveras-Ferraros C, Vellon L, Joven J, Vazquez-Martin A. Aging (Albany NY). 2011 Apr; 3(4):348-62.
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives. [Aging (Albany NY). 2010]
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives.
Blagosklonny MV. Aging (Albany NY). 2010 May; 2(5):265-73.
Review Validation of anti-aging drugs by treating age-related diseases. [Aging (Albany NY). 2009]
Review Validation of anti-aging drugs by treating age-related diseases.
Blagosklonny MV. Aging (Albany NY). 2009 Mar 28; 1(3):281-8. Epub 2009 Mar 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Is metformin a primary ovulatory agent in patients with polycystic ovary syndrom...
Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Gynecol Endocrinol. 2006 Nov ;22(11):595-604.

PubMed
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia...
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.
Haematologica. 2006 Dec ;91(12):1653-61.

PubMed
Future directions in vascular endothelial growth factor-targeted therapy for met...
Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancer.
Semin Oncol. 2006 Oct ;33(5 Suppl 10):S41-9.

PubMed
Pain perception and expression: the influence of gender, personal self-efficacy,...
Pain perception and expression: the influence of gender, personal self-efficacy, and lifespan socialization.
Pain Manag Nurs. 2006 Dec ;7(4):148-52.

PubMed
Methodological issues associated with group intervention research.
Methodological issues associated with group intervention research.
Arch Psychiatr Nurs. 2006 Dec ;20(6):276-81.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: